These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 32595469)

  • 1. Dramatic Response of Pulmonary Sarcomatoid Carcinoma to Nivolumab Combined with Anlotinib: A Case Report.
    Jin C; Yang B
    Case Rep Oncol; 2020; 13(2):601-605. PubMed ID: 32595469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case report: Sintilimab combined with anlotinib as neoadjuvant chemotherapy for metastatic bone tumor resection in patients with PSC.
    Bao Z; Yu X; Zheng K; Zhai K; Cui H; Xu M
    Front Immunol; 2024; 15():1372279. PubMed ID: 38756778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anlotinib combined with chemotherapy and immunotherapy for advanced pulmonary sarcomatoid cancer: a case report and literature review.
    Piao MN; Ma XT; Tankere P; Liam CK; Li JL; Wang JP
    Ann Transl Med; 2022 Sep; 10(18):1030. PubMed ID: 36267791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case Report: Advanced pulmonary sarcomatoid carcinoma with adrenal gland metastasis after sintilimab combined with anlotinib treatment.
    Dai G; He L; Yan Q; Li Y; Huang Y; Li B; Wang G
    Front Oncol; 2023; 13():1167516. PubMed ID: 37456237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pembrolizumab combined with anlotinib improves therapeutic efficacy in pulmonary sarcomatoid carcinoma with TMB-H and PD-L1 expression: a case report and literature review.
    Wu S; Wu S; Liao X; Zhou C; Qiu F; Wang C; Zhong W
    Front Immunol; 2023; 14():1274937. PubMed ID: 37936698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case Report: Pulmonary sarcomatoid carcinoma complicating TP53 mutation treated successfully with Tislelizumab combined with Anlotinib-a case report.
    Li YF; Zhao XF; Tian Y; Xiao XY; Yan CY; Shen H
    Front Genet; 2022; 13():949989. PubMed ID: 35938033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case report: A new promising treatment for pulmonary sarcomatoid carcinoma - Tislelizumab and Anlotinib combined with local radiotherapy.
    Cai R; Liu Y; Sha H; Yu J; Fang Y; Zhou G; Shen B
    Heliyon; 2023 Nov; 9(11):e21902. PubMed ID: 38027958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synchronal pulmonary sarcomatoid carcinoma and lung adenocarcinoma EML4-ALK fusion: A case report.
    Wang M; Gong Y; Cheng Y; Yang L; Wang W; Lei X
    Oncol Lett; 2022 Oct; 24(4):343. PubMed ID: 36072009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case report: Successful treatment of advanced pulmonary sarcomatoid carcinoma with BUBIB
    Huang N; Qu T; Zhang C; Li J
    Front Oncol; 2024; 14():1269148. PubMed ID: 38414747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anlotinib Combined With Chemotherapy for Recurrence of Pulmonary Sarcomatoid Cancer Previously Surgically Treated: A Case Report and Literature Review.
    Li J; Liang H; He J; Sui X; Qin Y
    Front Oncol; 2021; 11():639168. PubMed ID: 34046343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anlotinib combined with pembrolizumab as first-line treatment for advanced pulmonary sarcomatoid carcinoma: a case report and literature review.
    Wen Y; Dong Y; Yi L; Yang G; Xiao M; Li Q; Zhao C; Ye D; Yao Y
    Front Oncol; 2023; 13():1241475. PubMed ID: 37920159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case Report: Anlotinib Reverses Nivolumab Resistance in Advanced Primary Pulmonary Lymphoepithelioma-Like Carcinoma With FGFR3 Gene Amplification.
    Liu Y; Long L; Liu J; Zhu L; Luo F
    Front Oncol; 2021; 11():749682. PubMed ID: 34692530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significant benefits of pembrolizumab in treating refractory advanced pulmonary sarcomatoid carcinoma: A case report.
    Chen P; Yu M; Zhang JL; Chen WY; Zhu L; Song Y; Jiang CY; Zhang S
    World J Clin Cases; 2020 Jul; 8(13):2876-2884. PubMed ID: 32742998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dramatic response to nivolumab after local radiotherapy in pulmonary pleomorphic carcinoma with rapid progressive post-surgical recurrence.
    Yaguchi D; Ichikawa M; Ito M; Okamoto S; Kimura H; Watanabe K
    Thorac Cancer; 2019 May; 10(5):1263-1266. PubMed ID: 30860657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment Response to Immunotherapy After Crizotinib Resistance in a Patient With Pulmonary Sarcomatoid Carcinoma Harboring MET Exon 14 Skipping Mutation: A Case Report.
    Gu L; Wei X; Zhang Z; Heng W
    Clin Med Insights Oncol; 2022; 16():11795549211067185. PubMed ID: 35110965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PD-L1 and CD47 co-expression in pulmonary sarcomatoid carcinoma: a predictor of poor prognosis and potential targets of future combined immunotherapy.
    Yang Z; Xu J; Li R; Gao Y; He J
    J Cancer Res Clin Oncol; 2019 Dec; 145(12):3055-3065. PubMed ID: 31522278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inter-relationship between PD-L1 expression and clinic-pathological features and driver gene mutations in pulmonary sarcomatoid carcinomas.
    Lococo F; Torricelli F; Rossi G; Alifano M; Damotte D; Rapicetta C; Tamagnini I; Cavazza A; Piana S; Galeone C; Paci M; Ciarrocchi A
    Lung Cancer; 2017 Nov; 113():93-101. PubMed ID: 29110857
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Wu X; Huang Y; Li Y; Wang Q; Wang H; Jiang L
    Ann Nucl Med; 2019 Sep; 33(9):647-656. PubMed ID: 31165974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of immunotherapy in pulmonary sarcomatoid carcinoma: review of current approaches and related biomarkers.
    Ding K; Peng Z; Xu Y
    Ther Adv Med Oncol; 2024; 16():17588359241249041. PubMed ID: 38716479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in the management of pulmonary sarcomatoid carcinoma.
    Shum E; Stuart M; Borczuk A; Wang F; Cheng H; Halmos B
    Expert Rev Respir Med; 2016 Apr; 10(4):407-416. PubMed ID: 26962707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.